William Grossman
2020
In 2020, William Grossman earned a total compensation of $6.1M as Chief Medical Officer at Arcus Biosciences, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $2,073,420 |
| Salary | $457,600 |
| Stock Awards | $3,352,750 |
| Other | $1,200 |
| Total | $6,134,970 |
Grossman received $3.4M in stock awards, accounting for 55% of the total pay in 2020.
Grossman also received $250K in non-equity incentive plan, $2.1M in option awards, $457.6K in salary and $1.2K in other compensation.
Rankings
In 2020, William Grossman's compensation ranked 1,692nd out of 13,090 executives tracked by ExecPay. In other words, Grossman earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,692 out of 13,090 | 87th |
Division Manufacturing | 643 out of 5,621 | 89th |
Major group Chemicals And Allied Products | 231 out of 2,254 | 90th |
Industry group Drugs | 194 out of 1,954 | 90th |
Industry Pharmaceutical Preparations | 135 out of 1,459 | 91st |
Source: SEC filing on April 20, 2021.
Grossman's colleagues
We found five more compensation records of executives who worked with William Grossman at Arcus Biosciences in 2020.